Skip to content
Start Your Quest
Uncategorized

NRNP 6635 Bipolar Disorder Psychiatric Evaluation

5 min read

Bipolar disorder evaluations in NRNP 6635 test your ability to distinguish mania from hypomania, separate bipolar depression from unipolar depression and recognize when substance use or other conditions explain the picture. This guide walks through a bipolar disorder psychiatric evaluation with a fictional case, differentials and an evidence-based plan.

Quick answer

Identify the type of mood episode using DSM-5-TR duration and severity criteria: mania lasts at least one week (or any duration if hospitalized) with marked impairment, while hypomania lasts at least four days without marked impairment. Obtain collateral and family history, rule out substance-induced and medical causes and recommend first-line mood stabilizers or antipsychotics, avoiding antidepressant monotherapy.

The patient in this guide is fictional and is used for study purposes only. Diagnostic criteria are summarized in our own words; consult the DSM-5-TR directly for exact criteria, and base your evaluation on your assigned case.

The Case

Case summary

Fictional case: J.T., a 27-year-old man, is brought by his partner after nine days of sleeping 2–3 hours a night without feeling tired, talking rapidly, starting several business ventures and spending $8,000. He says, “I’ve never felt better; I’ve figured out how to fix the economy.” He had a depressive episode two years ago treated with sertraline. His mother has bipolar disorder. Urine drug screen negative. MSE: pressured speech, flight of ideas, grandiose content, euphoric and irritable affect, poor insight and judgment, no hallucinations.

Key DSM-5-TR Distinctions (Summarized)

FeatureManic episodeHypomanic episode
Mood and energyAbnormally elevated, expansive or irritable mood with increased activity or energySame
DurationAt least 1 week, most of the day nearly every day, or any duration if hospitalizedAt least 4 consecutive days
Symptoms3 or more (4 if mood only irritable): grandiosity, decreased need for sleep, pressured speech, flight of ideas, distractibility, increased goal-directed activity or agitation, risky activitiesSame symptom list
SeverityMarked impairment, hospitalization or psychotic featuresNo marked impairment or psychosis; observable change
DiagnosisBipolar I disorderBipolar II if there has also been a major depressive episode

Source: American Psychiatric Association (2022). J.T. meets criteria for a manic episode: nine days, more than three symptoms and marked impairment.

Differential Diagnoses

  1. Bipolar I disorder, current episode manic, severe: supported by duration, symptoms, impairment and family history.
  2. Substance/medication-induced bipolar disorder: negative drug screen argues against stimulants; consider whether the prior antidepressant played a role, though DSM-5-TR counts a full manic episode that persists beyond the physiological effect of treatment as bipolar I.
  3. Schizoaffective disorder, bipolar type: unlikely because there is no history of psychosis outside mood episodes. See schizophrenia and psychotic disorders case study.

Other conditions often confused with bipolar disorder include ADHD and borderline personality disorder, which have chronic rather than episodic courses.

Treatment Plan

  • Level of care: assess safety and consider hospitalization for severe mania with impaired judgment.
  • Pharmacotherapy: first-line options for acute mania include lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone and cariprazine, alone or in some combinations (Yatham et al., 2018). Stop or avoid antidepressants during mania.
  • Baseline labs: for lithium, renal function, thyroid function, calcium and pregnancy test when relevant; for valproate, liver function and CBC; for antipsychotics, weight, glucose or A1C and lipids.
  • Maintenance: continue effective acute treatment; lithium has strong evidence for relapse prevention (Yatham et al., 2018).
  • Psychoeducation: sleep regularity, early warning signs, adherence and family involvement.

Frequently Asked Questions

What is the difference between bipolar I and bipolar II?

Bipolar I requires at least one manic episode. Bipolar II requires at least one hypomanic episode and at least one major depressive episode, with no history of mania.

Why avoid antidepressant monotherapy in bipolar disorder?

It can be ineffective and may contribute to mood switching or destabilization; guidelines recommend mood stabilizers or specific antipsychotics.

What screening tool is used for bipolar disorder?

The Mood Disorder Questionnaire is a common screening tool, though diagnosis requires clinical assessment.

Get Help With Your Bipolar Disorder Evaluation at Collepals

Comprehensive psychiatric evaluations take time, and NRNP 6635 often requires a new one every few weeks. Collepals.com supports PMHNP students with:

  • Guidance on organizing your case into the comprehensive psychiatric evaluation template.
  • Help comparing DSM-5-TR criteria and building three well-supported differential diagnoses.
  • Current, evidence-based references formatted in APA 7.
  • Model evaluations, case presentations and reflections you can study, plus editing and proofreading of your drafts.

Browse our free model assignments or learn more about our nursing assignment writing service.

Get NRNP 6635 help at Collepals.com

Use Collepals examples as study guides and follow your university’s academic integrity and AI policies when you submit your own work.

More NRNP 6635 study guides

  • NRNP 6635 Comprehensive Psychiatric Evaluation: Complete Guide
  • How to Develop Three Differential Diagnoses in Psychiatric Evaluations
  • How to Compare DSM-5-TR Criteria in Psychiatric Case Studies
  • NRNP 6635 Major Depressive Disorder Case Study
  • How to Develop a Psychiatric Treatment Plan Using DSM-5-TR

Collepals is an independent study resource and is not affiliated with or endorsed by Walden University. Course requirements, templates and rubrics change; always follow your current syllabus and course template. This article is educational and is not clinical advice for any individual patient.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787

Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O’Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., … Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170. https://doi.org/10.1111/bdi.12609

Academic Writer & Editor
WhatsApp